November 22nd 2024
Reportedly, the child experienced mild symptoms and has received flu antivirals.
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Vaccine Shows Promise Against H5N1 Avian Influenza
June 11th 2008Two doses of a whole-virus vaccine against H5N1 avian influenza produced on Vero cell cultures induced neutralizing antibodies against multiple H5N1 strains, indicating its usefulness against this virus with pandemic potential, according to research published in the June 12 issue of the New England Journal of Medicine.
Rashes and Fever in Children: Sorting Out the Potentially Dangerous, Part 2
June 1st 2008Children who present with rash and fever can be divided into 3 groups: the first group includes those with features of serious illness who require immediate intervention. The second and third groups include those with clearly recognizable viral syndromes, and those with early or undifferentiated rash.
New insight into HPV infection in young males
May 5th 2008With all the talk over the past year about preventing human papilloma virus in girls, the fact that boys get HPV as well is often downplayed. A small study from researchers at the University of California, San Francisco, provided new insight into the under-recognized issue of HPV infection in young males.
Up close: Congenital and perinatal viral infections
May 4th 2008Neonatal viral infections are four to eight times more common than systemic bacterial diseases, but often go unrecognized. “Congenital cytomegalovirus (CMV) is one of the most common causes of infant death and permanent disability in America,” said Michael Cannon, PhD, Centers for Disease Control and Prevention, Atlanta.
Healthcare associated infections in the NICU
May 3rd 2008Nosocomial infections are a growing problem in the neonatal intensive care unit (NICU) along with methicillin-resistant Staph aureus (MRSA), vancomycin-resistant enterococci, multidrug- resistant gram negative organisms, Candida and respiratory virii.
CDC: Influenza season in 2007-2008 was moderately severe
April 21st 2008According to interim results of a study by the Centers for Disease Control and Prevention (CDC), the 2007-2008 influenza season was moderately severe, and two of three vaccine strains were not optimally matched with circulating viruses.
Genetic Influence on Fears Changes Over Time
April 8th 2008Genetic and environmental factors both have an impact on fears in middle childhood and early adulthood but they act in a dynamic way and change over time, according to a report published in the April issue of the Archives of General Psychiatry.
Bedroom Television Bad Influence on Teens
April 7th 2008Older adolescents who have a television in their bedroom are less physically active, have fewer family meals and a poorer diet compared to their counterparts without a bedroom television, according to a report published in the April issue of Pediatrics.
FDA: Safety Warning Issued for Influenza Drug Relenza
April 3rd 2008The maker of the antiviral drug Relenza (zanamivir) informed health care professionals this week of a potential risk of behavioral changes and delirium associated with the drug's use. Relenza is approved for the treatment of influenza A and B.
FDA: Delirium Tied to Use of Tamiflu in Influenza
March 5th 2008The U.S. Food and Drug Administration, together with Roche Laboratories, Inc., the maker of Tamiflu (oseltamivir), have informed health care professionals of neuropsychiatric events associated with use of the antiviral drug in patients with influenza. The Tamiflu package insert has been updated to reflect these safety concerns.
FDA: Delirium Tied to Use of Tamiflu in Influenza
March 5th 2008The U.S. Food and Drug Administration, together with Roche Laboratories, Inc., the maker of Tamiflu (oseltamivir), have informed health care professionals of neuropsychiatric events associated with use of the antiviral drug in patients with influenza. The Tamiflu package insert has been updated to reflect these safety concerns.
FDA Agrees to Expand Next Year's Influenza Vaccine
February 22nd 2008The U.S. Food and Drug Administration announced plans this week to expand next year's flu vaccine by including three new flu strains, in the hopes of producing a vaccine that is more effective than this year's vaccine. Researchers at the U.S. Centers for Disease Control and Prevention report on this season's flu activity in the Feb. 15 issue of the Morbidity and Mortality Weekly Report.